1. |
Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom, 2013, 16(1):33-39.
|
2. |
Rejnmark L, Amstrup AK, Mollerup CL, et al. Further insights into the pathogenesis of primary hyperparathyroidism:a nested case-control study. J Clin Endocrinol Metab, 2013, 98(1):87-96.
|
3. |
Lewiecki EM, Miller PD. Skeletal effects of primary hyperparathyroi-dism:bone mineral density and fracture risk. J Clin Densitom, 2013, 16(1):28-32.
|
4. |
吴全, 崔爱民, 柏楠, 等. 73例原发性甲状旁腺功能充进症的诊治分析.中国普外基础与临床杂志, 2013, 20(7):776-778.
|
5. |
Wémeau JL. Primary hyperparathyroidism. J Radiol, 2009, 90(3 Pt 2):392-396.
|
6. |
邬鹏跃, 张一秋, 石洪成.放射性核素检查在甲状旁腺腺瘤诊断中的应用.中国临床医学, 2012, 19(6):717-718.
|
7. |
李荣红.原发性甲状旁腺功能亢进症的临床特点分析及治疗观察.大家健康, 2014, 8(9):131.
|
8. |
游振辉, 黄东航, 顾恩郁, 等.原发性甲状旁腺功能亢进症的术前定位诊断.中华内分泌代谢杂志, 2004, 20(4):331-332.
|
9. |
Yip L, Pryma DA, Yim JH, et al. Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism. World J Surg, 2009, 33(3):426-433.
|
10. |
中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组.原发性甲状旁腺功能亢进症诊疗指南.中华医学会骨质疏松和骨矿盐疾病杂志, 2014, 7(3):187-198.
|
11. |
DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism:a current perspective. Arch Pathol Lab Med, 2008, 132(8):1251-1262.
|
12. |
王欧, 邢小平, 孟迅吾, 等.不同病理类型原发性甲状旁腺功能亢进症临床表现的比较分析.中国实用内科杂志, 2006, 26(22):.
|
13. |
张悦, 张遵城, 李小东, 等. 99Tcm-MIBI双时相显像双时相核素显像在原发性甲旁亢术前定位诊断中的应用.天津医科大学学报, 2010, 16(4):669-670.
|
14. |
Wu HS, Liu YC, Kao A, et al. Using technetium 99m tetrofosmin parathyroid imaging to detect parathyroid adenoma and its relation to P-glycoprotein expression. Surgery, 2002, 132(3):456-460.
|
15. |
Shiau YC, Tsai SC, Wang JJ, et al. Detecting parathyroid adenoma using technetium-99m tetrofosmin:comparison with P-glycopro-tein and multidrug resistance related protein expression-a prelimi-nary report. Nucl Med Biol, 2002, 29(3):339-344.
|
16. |
Kao A, Shiau YC, Tsai SC, et al. Technetium-99m methoxyisobuty-lisonitrile imaging for parathyroid adenoma:relationship to P-glycoproteinor multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging, 2002, 29(8):1012-1015.
|
17. |
汪太松, 赵晋华, 邢岩. 99Tcm-MIBI SPECT/CT双时相显像对原发性甲状旁腺功能亢进症的诊断价值.中国医学影像学杂志, 2012, 20(11):855-857.
|
18. |
Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization. Nucl Med Commu, 2003, 24(2):121-124.
|
19. |
Levy JM, Kandil E, Yau LC, et al. Can ultrasound be used as the primary screening modality for the localization of parathyroid-disease prior to surgery for primary hyperparathyroidism? A review of 440 cases. ORL J Otorhinolaryngol Relat Spec, 2011, 73(2):116-120.
|
20. |
Akbaba G, Berker D, Isik S, et al. A comparative study of pre-opera-tive imaging methods in patients with primary hyperparathyroi-dism:ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging. J Endocrinol Invest, 2012, 35(4):359-364.
|
21. |
Witteveen JE, Kievit J, Stokkel MP, et al. Limitations of 99Tcm MIBI-SPECT imaging scans in persistent primary hyperparathy-roidism. World J Surg, 2011, 35(1):128-139.
|
22. |
Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1 650 consecutive patients with primary hyperparathyroidism. Ann Surg, 2011, 253(3):585-591.
|
23. |
Wilson SD, Doffek KM, Wang TS, et al. Primary hyperparath-yroidism with a history of head and neck irradiation:the conseq-uences of associated thyroid tumors. Surgery, 2011, 150(4):869-877.
|
24. |
Cating-Cabral MT, Cabungcal AC, Villafuerte CV 3rd, et al. Primary hyperparathyroidism due to an intrathyroidal parathyroid adenoma associated with chronic lymphocytic thyroiditis. BMJ Case Rep, 2012, 6(8):2012. pii:bcr2012006198.
|
25. |
张祥铭, 张敏, 胡佳佳, 等. 99Tcm-甲氧基异丁基异腈双时相平面显像和99Tcm-MIBI SPECT/CT断层显像诊断原发性甲状旁腺功能亢进症.中国医学影像技术, 2014, 30(6):850-853.
|
26. |
张连娜, 杨芳, 冯瑾.原发性甲状旁腺功能亢进症的SPECT/CT诊断.中国医学计算机成像杂志, 2014, 20(1):64-67.
|
27. |
赵海鹰, 杨福全, 田忠, 等.超声、CT与99Tcm-MIBI核素扫描在原发性甲状旁腺功能亢进症中的诊断价值比较及其漏诊原因分析.中国普外基础与临床杂志, 2013, 20(9):1038-1044.
|
28. |
Kim YI, Jung YH, Hwang KT, et al. Efficacy of 99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy:comparative study with 99mTc-sestamibi scintigraphy, SPECT, US and CT. Ann Nucl Med, 2012, 6(10):804-810.
|